Scott M Starling

Title: **Innovative Contributions of Scott M Starling in Drug Delivery Systems**

Introduction

Scott M Starling is a notable inventor based in Bexley, Australia, recognized for his innovative contributions to controlled drug delivery systems. With a focus on developing advanced pharmaceutical technologies, he has made significant strides in enhancing the efficiency of drug administration.

Latest Patents

Starling holds a patent titled "Surface cross-linked particles suitable for controlled delivery." This invention relates to the creation of cross-linked particles that are pivotal for the delivery of pharmaceutical agents. These specialized particles incorporate polymeric compounds and spacer compounds, which possess reactive carboxyl, hydrazidyl, amino, and/or thiol groups. The cross-linking is achieved through covalent bonds formed between the reactive groups of the polymer and spacer. His patent further details the methods for preparing these particles, encapsulating pharmaceutical agents, and utilizing them for controlled release within patients.

Career Highlights

Scott M Starling is associated with Biotech Australia Pty Ltd, a company that is at the forefront of biotechnological advancements. His work reflects a commitment to improving pharmaceutical delivery methods, showcasing his expertise in biochemistry and material science.

Collaborations

During his career, Starling has collaborated with distinguished professionals, including Gregory John Russell-Jones and John F McEwan. These collaborations have undoubtedly contributed to the advancements in his research and the successful development of his patented technology.

Conclusion

In summary, Scott M Starling's innovative work on polymeric particles for controlled drug delivery stands as a significant achievement in the realm of pharmaceuticals. His contributions not only highlight his capabilities as an inventor but also his dedication to advancing medical technologies for better patient outcomes.